Qiagen (QGEN) Research & Development (2009 - 2025)

Qiagen has reported Research & Development for 17 years, with the latest figure at $120.7 million in Q4 2025.

• Quarterly Research & Development rose 6.05% year-over-year to $120.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $458.0 million (up 1.57% YoY) and the FY2025 annual result came in at $458.0 million, up 1.57% from the prior year.
• Research & Development rose to $120.7 million in Q4 2025 per QGEN's latest filing, from $112.8 million in the prior quarter.
• Over five years, Research & Development peaked at $122.2 million in Q4 2022 and troughed at $106.3 million in Q1 2025.
• A 5-year average of $115.1 million and a median of $114.6 million in 2023 frame the typical range for Research & Development.
• The sharpest annual moves came in 2021 and 2025: Research & Development climbed 18.8% in 2021, then slipped 4.31% in 2025.
• Over 5 years, Research & Development stood at $119.4 million in 2021, then grew by 2.4% to $122.2 million in 2022, then slipped by 3.9% to $117.5 million in 2023, then slipped by 3.08% to $113.9 million in 2024, then climbed by 6.05% to $120.7 million in 2025.
• According to Business Quant data, Research & Development over the past three periods registered $120.7 million, $112.8 million, and $118.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.